Company news

Indivior Pharmaceuticals, Inc. news in 2026

Indivior Pharmaceuticals, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Indivior Reports Third Quarter 2026 Financial Results

October 29, 2026

Indivior to Report Third Quarter 2026 Financial Results

October 19, 2026

Shareholders Approve Proposed Merger with Supernus

October 15, 2026

Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend

September 17, 2026

Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

August 3, 2026

Indivior to Report Second Quarter 2026 Financial Results and Host Webcast

July 23, 2026

New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization

May 20, 2026

Indivior Announces $175 Million Accelerated Share Repurchase

May 4, 2026

Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance

April 30, 2026

Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder

April 24, 2026

Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse

April 16, 2026

Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th

April 9, 2026

New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities

March 31, 2026

National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder

March 17, 2026

Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering

March 11, 2026

Indivior Announces Proposed Convertible Senior Notes Offering

March 11, 2026

New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder

March 11, 2026

Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results

February 25, 2026

Indivior to Participate in Upcoming Investor Conferences

February 24, 2026

Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26??

January 29, 2026

Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ

January 28, 2026

Indivior Announces Completion of Redomiciliation to the United States

January 25, 2026

Indivior Provides Full-Year 2026 Financial Guidance and Business Update

January 7, 2026

Calls in 2026

Decks in 2026